National Institute for Health and Clinical Excellence (NICE) and Targeted Therapies for Metastatic Renal Cell Carcinoma (Feature Article) (Report) National Institute for Health and Clinical Excellence (NICE) and Targeted Therapies for Metastatic Renal Cell Carcinoma (Feature Article) (Report)

National Institute for Health and Clinical Excellence (NICE) and Targeted Therapies for Metastatic Renal Cell Carcinoma (Feature Article) (Report‪)‬

Advances in Oncology 2010, Dec, 5, 4

Advances in Oncology
    • $5.99
    • $5.99

Publisher Description

Introduction Renal cell carcinoma (RCC) accounts for 2% of all cancer deaths in the United Kingdom [1]. Whilst RCC localised to the kidney can be treated with radical nephrectomy [2], those presenting with locally invasive or metastatic cancer provide a far more difficult treatment challenge, as metastatic renal cell carcinoma (mRCC) is poorly responsive to radiotherapy and notoriously chemo resistant [3], with a poor prognosis of 6-10 months median survival [4].

GENRE
Health, Mind & Body
RELEASED
2010
December 1
LANGUAGE
EN
English
LENGTH
8
Pages
PUBLISHER
Mediscript Ltd.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
211.9
KB

More Books by Advances in Oncology

The Role of Biologicals in the Management of Metastatic Colorectal Cancer (Feature Article: Gastrointestinal Cancer) (Clinical Report) The Role of Biologicals in the Management of Metastatic Colorectal Cancer (Feature Article: Gastrointestinal Cancer) (Clinical Report)
The Role of Biologicals in the Management of Metastatic Colorectal Cancer (Feature Article: Gastrointestinal Cancer) (Clinical Report)
2009
American Society of Clinical Oncology (ASCO): Chicago, USA, 4-8 June 2010 (Conference Report: ASCO 2010) American Society of Clinical Oncology (ASCO): Chicago, USA, 4-8 June 2010 (Conference Report: ASCO 2010)
American Society of Clinical Oncology (ASCO): Chicago, USA, 4-8 June 2010 (Conference Report: ASCO 2010)
2010
Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report) Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report)
Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report)
2010
The Future Is Brite (Feature Article) (Clinical Report) The Future Is Brite (Feature Article) (Clinical Report)
The Future Is Brite (Feature Article) (Clinical Report)
2009
Therapeutic Mammoplasty: A Fusion of Oncological and Aesthetic Breast Surgery (Breast Cancer) (Report) Therapeutic Mammoplasty: A Fusion of Oncological and Aesthetic Breast Surgery (Breast Cancer) (Report)
Therapeutic Mammoplasty: A Fusion of Oncological and Aesthetic Breast Surgery (Breast Cancer) (Report)
2010
Myths Give Way to the New Realities of Oncology (Clinical Report) Myths Give Way to the New Realities of Oncology (Clinical Report)
Myths Give Way to the New Realities of Oncology (Clinical Report)
2008